Sarcoidosis of the Nervous System

Aminoff's Neurology and General Medicine: Fifth Edition

Volumn , Issue , 2014, Pages 985-1002

  Krumholz, Allan ^a   Stern, Barney J ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cranial neuropathies; CSF; Immunosuppression; Inflammation; MRI; Neurosarcoidosis; Sarcoidosis; Systemic disease

Indexed keywords

EID: 84903857443     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-407710-2.00049-7     Document Type: Chapter

References (93)

1. James DG, Williams WJ Sarcoidosis and Other Granulomatous Disorders 1985, WB Saunders, Philadelphia.
2. Burns TM Neurosarcoidosis. Arch Neurol 2003, 60:1166.
3. Lieberman J, Kataria YP, Young JRL Historical perspective of sarcoidosis. Sarcoidosis 1985, 1. Grune & Stratton, Orlando, FL. J. Lieberman (Ed.).
4. Johns CJ, Michele TM The clinical management of sarcoidosis: a 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 1999, 78:65.
5. Heerfordt C Uber eine 'Febrid uveo-parotidea subchronica' an den Glandula parotis und der Uvea des Auges lokalisiert und haufig mit Paresencerebrospinaler Nerven kompliziert. Albrecht v. Graefes. Arch Ophthalmol 1909, 70:254.
6. Stern BJ, Krumholz A, Johns C, et al. Sarcoidosis and its neurological manifestations. Arch Neurol 1985, 42:909.
7. Krumholz A, Stern BJ Neurological manifestations of sarcoidosis. Handbook of Clinical Neurology, Vol 71: Systemic Diseases (Part III) 1998, 463. Elsevier, Amsterdam. M.J. Aminoff, C.G. Goetz (Eds.).
8. Terushkin V, Stern BJ, Judson MA, et al. Neurosarcoidosis: presentations and management. Neurologist 2010, 16:2.
9. Pawate S, Moses H, Sriram S Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM 2009, 102:449.
10. Joseph FG, Scolding NJ Sarcoidosis of the nervous system. Pract Neurol 2007, 7:234.
11. Younger DS, Hays AP, Brust JC, et al. Granulomatous angiitis of the brain: an inflammatory reaction of diverse etiology. Arch Neurol 1988, 45:514.
12. Luke RA, Stern BJ, Krumholz A, et al. Neurosarcoidosis: the long-term clinical course. Neurology 1987, 37:461.
13. Krumholz A, Stern BJ, Stern EG Clinical implications of seizures in neurosarcoidosis. Arch Neurol 1991, 48:842.
14. James DG, Turlaf J, Hosoda Y, et al. Description of sarcoidosis: report of the subcommittee on classification and definition. Ann NY Acad Sci 1976, 278:742.
15. Weinberg S, Bennett H, Weinstock I CNS manifestations of sarcoidosis in children. Clin Pediatr 1983, 22:447.
16. Iannuzzi MC, Rybicki BA, Teirstein AS, Sarcoidosis.N, Engl J Med 2007, 357:2153.
17. Nozaki K, Scott TF, Sohn M, Judson MA Isolated neurosarcoidosis: case series in 2 sarcoidosis centers. Neurologist 2012, 18:373.
18. Tanoue LT, Zitnik R, Elias JA Systemic sarcoidosis. Textbook of Pulmonary Diseases 1994, 745. Little, Brown, Boston. G.L. Baum, E. Wolinsky (Eds.).
19. Hoitsma E, Drent M, Sharma OP A pragmatic approach to diagnosing and treating sarcoidosis in the 21st century. Curr Opin Pulm Med 2010, 16:472.
20. Agbogu BN, Stern BJ, Swell C, et al. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995, 52:875.
21. James DG: State-of-the art lecture: etiology of sarcoidosis. p. 43. In Sharma OP (ed): Proceedings of the Fourteenth International Conference on Sarcoidosis and Other Granulomatous Disorders. Edizioni Bongraf, Milan, 1994.
22. Semenzato G, Agostinit C: State-of-the art lecture: immunopathologies of sarcoidosis. p. 59. In Sharma OP (ed): Proceedings of the Fourteenth International Conference on Sarcoidosis and Other Granulomatous Disorders. Edizioni Bongraf, Milan, 1994.
23. Weissler JC Southwestern internal medicine conference: sarcoidosis: immunology and clinical management. Am J Med Sci 1994, 307:233.
24. Moller DR Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999, 16:25.
25. Myatt N, Coghill GK, Morrison K, et al. Detection of tumour necrosis factor in sarcoidosis and tuberculosis granulomas using situ hybridization. J Clin Pathol 1994, 47:423.
26. Thomas PD, Hunninghake GW Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987, 135:747.
27. Joyce-Brady M Tastes great, less filling: the debate about mycobacteria and sarcoidosis. Am Rev Respir Dis 1992, 145:986.
28. Popper HH, Winter E, Hofler G DNA of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissue in tuberculosis and sarcoidosis detected by polymerase chain reaction. Am J Clin Pathol 1994, 101:738.
29. Ghossein RA, Ross DG, Salomon RN, et al. A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction. Am J Clin Pathol 1994, 101:733.
30. Muller-Quernheim J Sarcoidosis: immunopathogenic concepts and their clinical application. Eur Respir J 1998, 112:716.
31. Ishige I, Usui Y, Takemura T, et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999, 354:120.
32. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Resp Crit Care Med 2001, 164:2085.
33. Hofmann S, Franke A, Fischer A, et al. Genome-wide association study identifies ANXA11 as a susceptibility locus for sarcoidosis. Nat Genet 2008, 40:1103.
34. Smith G, Brownel I, Sanchez M, Prystowsky S Advances in the genetics of sarcoidosis. Clin Genet 2008, 73:401.
35. Zajicek JP, Entzian P, Dalhoff K, et al. Central nervous system sarcoidosis-diagnosis and management. QJM 1999, 92:103.
36. Graham EM, Ellis CJK, Sanders MD Optic neuropathy in sarcoidosis. J Neurol Neurosurg Psychiatry 1986, 49:756.
37. Colvin IB Audiovestibular manifestations of sarcoidosis: a review of the literature. Laryngoscope 2006, 116:75.
38. Tobias JK, Santiago SM, Williams AJ Sarcoidosis as a cause of left recurrent laryngeal nerve palsy. Arch Otolaryngol Head Neck Surg 1990, 116:971.
39. Plotkin GR, Patel BR Neurosarcoidosis presenting as chronic lymphocytic meningitis. Pennsylvania Med 1986, 89:36.
40. Osenbach RK, Blumenkopf BH, Ramirez H, et al. Meningeal neurosarcoidosis mimicking convexity en-plaque meningioma. Surg Neurol 1986, 26:387.
41. Sethi KD, El Gammal T, Patel BR, et al. Dural sarcoidosis presenting with transient neurologic symptoms. Arch Neurol 1986, 43:595.
42. Scott TF Cerebral herniation after lumbar puncture in sarcoid meningitis. Clin Neurol Neurosurg 2000, 102:26.
43. Schlitt M, Duvall ER, Bonnin J, et al. Neurosarcoidosis causing ventricular loculation, hydrocephalus, and death. Surg Neurol 1986, 26:67.
44. Capellan JI, Cuellar Olmedo L, Martinez Martin J, et al. Intrasellar mass with hypopituitarism as a manifestation of sarcoidosis. J Neurosurg 1990, 73:283.
45. Missler U, Mack M, Nowack G Pituitary sarcoidosis. Klin Wochenschr 1990, 68:342.
46. Bihan H, Christozova V, Dumas J-L Sarcoidosis: clinical hormonal, and magnetic imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Medicine (Baltimore) 2007, 86:259.
47. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 1990, 69:261.
48. Cordingley G, Navarro C, Brust JCM Sarcoidosis presenting as senile dementia. Neurology 1981, 31:1148.
49. Meyer J, Foley J, Campagna-Pinto D Granulomatous angiitis of the meninges in sarcoidosis. Arch Neurol 1953, 69:587.
50. Brown MM, Thompson AJ, Wedzicha JA, et al. Sarcoidosis presenting with stroke. Stroke 1989, 20:400.
51. Corse AM, Stern BJ Neurosarcoidosis and stroke. Stroke 1990, 21:152.
52. Caplan L, Corbett J, Goodwin J, et al. Neuro-ophthalmologic signs in the angiitic form of neurosarcoidosis. Neurology 1983, 33:1130.
53. Joseph FG, Scolding NJ Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry 2008, 80:297.
54. Junger SS, Stern BJ, Levin E Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology 1993, 43:333.
55. Olek M, Jaitly R, Kuta A Sarcoidosis and spinal cord atrophy. Neurologist 1995, 1:240.
56. Zuniga G, Ropper AH, Frank J Sarcoid peripheral neuropathy. Neurology 1991, 41:1558.
57. Hoitsma E, Marziniak M, Faber CG, et al. Small fiber neuropathy in sarcoidosis. Lancet 2002, 359:2085.
58. Dreyer M, Vucic S, Cros DP, et al. Multiple painful sensory mononeuropathies (MPSM), a novel pattern of sarcoid neuropathy. J Neurol Neurosurg Psychiatry 2004, 75:1645.
59. Judson MA Small fiber neuropathy in sarcoidosis: something beneath the surface. Respir Med 2011, 105:1.
60. Bakkers M, Merkies ISJ, Lauria G, et al. Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 2009, 3:1142.
61. Ando DG, Lynch JP, Fantone CJ III: Sarcoid myopathy with elevated creatine phosphokinase. Am Rev Respir Dis 1985, 131:298.
62. Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis Vas Diffuse Lung Dis 1999, 16:15.
63. Savolaine ER, Schlembach PJ Gallium scan diagnosis of sarcoidosis in the presence of equivocal radiographic and CT findings: value of lacrimal gland biopsy. Clin Nucl Med 1990, 15:198.
64. Dubey N, Miletich RS, Wasay M, et al. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci 2002, 205:77.
65. Chan Seem CP, Norfolk G, Spokes EG CSF angiotensin-converting enzyme in neurosarcoidosis. Lancet 1985, 1:456.
66. Tahmoush AJ, Amir MS, Connor WW, et al. CSF-ACE activity in probable neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002, 19:191.
67. Dale JC, O'Brien JF Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc 1999, 74:535.
68. Sherman JL, Stern BJ Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. Am J Neuroradiol 1990, 11:915.
69. Scott TF, Yandora K, Kunschere LJ, et al. Neurosarcoidosis mimicry of multiple sclerosis: clinical, laboratory, and imaging characteristics. Neurologist 2010, 16:386.
70. Reske D, Petereit H-F, Heiss W-D Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system-value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis. Acta Neurol Scand 2005, 112:207.
71. Streletz LJ, Chambers RA, Bae SH Visual evoked potentials in sarcoidosis. Neurology 1981, 31:1545.
72. Oksanen V, Salmi T Visual and auditory evoked potentials in the early diagnosis and follow-up of neurosarcoidosis. Acta Neurol Scand 1986, 74:38.
73. Stern BJ, Schonfeld SA, Sewell C, et al. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992, 49:1065.
74. Challenor YB, Felton CP, Brust JCM Peripheral nerve involvement in sarcoidosis: an electrodiagnostic study. J Neurol Neurosurg Psychiatry 1984, 47:1219.
75. Otake S, Banno T, Ohaba S Muscular sarcoidosis: findings at MR imaging. Radiology 1990, 176:145.
76. Soucek D, Prior C, Loef G Successful treatment of spinal sarcoidosis by high-dose intravenous methylprednisolone. Clin Neuropharmacol 1993, 16:464.
77. Keenan GF Management of complications of glucocorticoid therapy. Clin Chest Med 1997, 18:507.
78. Schneyer CR Abnormal bone metabolism in a neurological setting. Neurologist 1995, 1:259.
79. Scott TF, Yandora K, Valeri A, et al. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol 2007, 64:691.
80. Androdias G, Mailler D, Marignier R, et al. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy. Neurology 2011, 76:1168.
81. Moravan M, Segal BM Treatment of CNS sarcoidosis with infliximab and myocphenolatemofetil. Neurology 2009, 72:338.
82. Lower EE, Baughman RP The use of low-dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990, 299:153.
83. Lower EE, Baughman RP Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995, 155:846.
84. Lower EE, Broderick JP, Brott TG, et al. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997, 157:1864.
85. Katz JM, Bruno MK, Winterkorn JMS, et al. The pathogenesis and treatment of optic disc swelling in neurosarcoidosis: a unique therapeutic response to infliximab. Arch Neurol 2003, 60:426.
86. Pettersen JA, Zochodne DW, Bell RB, et al. Refractory neurosarcoidosis responding to infliximab. Neurology 2002, 59:1660.
87. Kobylecki C, Shaunak S Refractory neurosarcoidosis responsive to infliximab. Pract Neurol 2007, 7:112.
88. Santos E, Shaunak S, Renowden S Treatment of refractory neurosarcoidosis with infliximab. J Neurol Neurosurg Psychiatry 2010, 81:241.
89. Heffernan MP, Smith DI Adalimumab for treatment of cutaneous sarcoidosis. Arch Dermatol 2006, 142:17.
90. Parambil JG, Tavee JO, Zhou L, et al. Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir Med 2011, 105:101.
91. Bomprezzi R, Pati S, Chansakul C A case of neurosarcoidosis successfully treated with rituximab. Neurology 2010, 75:568.
92. Ahmad K, Kim YH, Spitzer AR, et al. Total nodal radiation in progressive sarcoidosis. Am J Clin Oncol 1992, 15:311.
93. Ferriby D, de Seze J, Stojkovic T, et al. Long-term follow-up of neurosarcoidosis. Neurology 2001, 57:927.